Prostaglandins As PPARγ Modulators in Adipogenesis

Overview

Journal PPAR Res

Publisher Wiley

Date 2013 Jan 16

PMID 23319937

Citations 23

Authors

Ko Fujimori

Affiliations

Soon will be listed here.

Abstract

Adipocytes and fat cells play critical roles in the regulation of energy homeostasis. Adipogenesis (adipocyte differentiation) is regulated via a complex process including coordinated changes in hormone sensitivity and gene expression. PPARγ is a ligand-dependent transcription factor and important in adipogenesis, as it enhances the expression of numerous adipogenic and lipogenic genes in adipocytes. Prostaglandins (PGs), which are lipid mediators, are associated with the regulation of PPARγ function in adipocytes. Prostacyclin promotes the differentiation of adipocyte-precursor cells to adipose cells via activation of the expression of C/EBPβ and δ. These proteins are important transcription factors in the activation of the early phase of adipogenesis, and they activate the expression of PPARγ, which event precedes the maturation of adipocytes. PGE(2) and PGF(2α) strongly suppress the early phase of adipocyte differentiation by enhancing their own production via receptor-mediated elevation of the expression of cycloxygenase-2, and they also suppress the function of PPARγ. In contrast, PGD(2) and its non-enzymatic metabolite, Δ(12)-PGJ(2), activate the middle-late phase of adipocyte differentiation through both DP2 receptors and PPARγ. This paper focuses on potential roles of PGs as PPARγ modulators in adipogenesis and regulators of obesity.

Citing Articles

Aspirin Inhibits the In Vitro Adipogenic Differentiation of Human Adipose Tissue-Derived Stem Cells in a Dose-Dependent Manner.

Funke S, Wiggenhauser P, Grundmeier A, Fuchs B, Koban K, Demmer W Int J Mol Sci. 2025; 26(2).

PMID: 39859567 PMC: 11766433. DOI: 10.3390/ijms26020853.

Investigating the crosstalk between and in 3T3-L1 adipocyte differentiation.

Laddha A, Wahane A, Bahal R, Manautou J Front Mol Biosci. 2024; 11:1498946.

PMID: 39717760 PMC: 11663720. DOI: 10.3389/fmolb.2024.1498946.

Uncovering the Role of Selenite and Selenium Nanoparticles (SeNPs) in Adolescent Rat Adipose Tissue beyond Oxidative Balance: Transcriptomic Analysis.

Nogales F, Pajuelo E, Romero-Herrera I, Carreras O, Merchan F, Carrasco Lopez J Antioxidants (Basel). 2024; 13(6).

PMID: 38929188 PMC: 11200624. DOI: 10.3390/antiox13060750.

Prostaglandin F2α Affects the Cycle of Clock Gene Expression and Mouse Behavior.

Tsurudome Y, Yoshida Y, Hamamura K, Ogino T, Yasukochi S, Yasuo S Int J Mol Sci. 2024; 25(3).

PMID: 38339119 PMC: 10855224. DOI: 10.3390/ijms25031841.

Hypoabsorptive surgeries cause limb-dependent changes in the gut endocannabinoidome and microbiome in association with beneficial metabolic effects.

Mukorako P, St-Pierre D, Flamand N, Biertho L, Lebel S, Lemoine N Int J Obes (Lond). 2023; 47(7):630-641.

PMID: 37142736 DOI: 10.1038/s41366-023-01307-3.

References

Penumetcha M, Santanam N . Nutraceuticals as Ligands of PPARγ. PPAR Res. 2012; 2012:858352. PMC: 3388323. DOI: 10.1155/2012/858352. View

Tabe Y, Konopleva M, Andreeff M, Ohsaka A . Effects of PPARγ Ligands on Leukemia. PPAR Res. 2012; 2012:483656. PMC: 3364693. DOI: 10.1155/2012/483656. View

Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I . Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000; 275(42):32775-82. DOI: 10.1074/jbc.M003504200. View

Murakami M, Taketomi Y, Miki Y, Sato H, Hirabayashi T, Yamamoto K . Recent progress in phospholipase A₂ research: from cells to animals to humans. Prog Lipid Res. 2010; 50(2):152-92. DOI: 10.1016/j.plipres.2010.12.001. View

Kanaoka Y, Urade Y . Hematopoietic prostaglandin D synthase. Prostaglandins Leukot Essent Fatty Acids. 2003; 69(2-3):163-7. DOI: 10.1016/s0952-3278(03)00077-2. View

Ghoshal S, Trivedi D, Graf G, Loftin C . Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J Biol Chem. 2010; 286(1):889-98. PMC: 3013048. DOI: 10.1074/jbc.M110.139139. View

Sharma A, Staels B . Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab. 2006; 92(2):386-95. DOI: 10.1210/jc.2006-1268. View

Yan H, Kermouni A, Abdel-Hafez M, Lau D . Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res. 2003; 44(2):424-9. DOI: 10.1194/jlr.M200357-JLR200. View

Chu X, Nishimura K, Jisaka M, Nagaya T, Shono F, Yokota K . Up-regulation of adipogenesis in adipocytes expressing stably cyclooxygenase-2 in the antisense direction. Prostaglandins Other Lipid Mediat. 2009; 91(1-2):1-9. DOI: 10.1016/j.prostaglandins.2009.10.002. View

10.

Narumiya S, Furuyashiki T . Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years. FASEB J. 2011; 25(3):813-8. DOI: 10.1096/fj.11-0302ufm. View

11.

Serrero G, Lepak N . Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997; 233(1):200-2. DOI: 10.1006/bbrc.1997.6433. View

12.

Matsuzawa Y . Adiponectin: a key player in obesity related disorders. Curr Pharm Des. 2010; 16(17):1896-901. DOI: 10.2174/138161210791208893. View

13.

Miller C, Casimir D, Ntambi J . The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha. Endocrinology. 1996; 137(12):5641-50. DOI: 10.1210/endo.137.12.8940395. View

14.

Bell-Parikh L, Ide T, Lawson J, McNamara P, Reilly M, FitzGerald G . Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest. 2003; 112(6):945-55. PMC: 193665. DOI: 10.1172/JCI18012. View

15.

Smith W, Urade Y, Jakobsson P . Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev. 2011; 111(10):5821-65. PMC: 3285496. DOI: 10.1021/cr2002992. View

16.

Sugimoto Y, Tsuboi H, Okuno Y, Tamba S, Tsuchiya S, Tsujimoto G . Microarray evaluation of EP4 receptor-mediated prostaglandin E2 suppression of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun. 2004; 322(3):911-7. DOI: 10.1016/j.bbrc.2004.07.194. View

17.

Jakobsson P, Thoren S, Morgenstern R, Samuelsson B . Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A. 1999; 96(13):7220-5. PMC: 22058. DOI: 10.1073/pnas.96.13.7220. View

18.

Krey G, Braissant O, LHorset F, Kalkhoven E, Perroud M, Parker M . Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol. 1997; 11(6):779-91. DOI: 10.1210/mend.11.6.0007. View

19.

Legler D, Bruckner M, Uetz-von Allmen E, Krause P . Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol. 2009; 42(2):198-201. DOI: 10.1016/j.biocel.2009.09.015. View

20.

Hossain M, Chowdhury A, Rahman M, Nishimura K, Jisaka M, Nagaya T . Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. Prostaglandins Other Lipid Mediat. 2011; 94(3-4):73-80. DOI: 10.1016/j.prostaglandins.2010.12.005. View